01

Biotech insights for the future

02
Case Studies
Hit Identification – SARM1 Structural Elucidation By Internal Cryo-EM Platform
Identifying Novel FGFR3 Inhibitors By XtalPi-Curated HTS Diversity Library
Hit Identification – Novel Hits for GPX4
Lead Identification – Discovering Selective Inhibitors Against an Unreported Binding Pocket of SMARCA2 via a Rational Drug Design Approach
04
Video Library
Unlock Faster, Smarter Polymorph Screening with XtalGazer™ CSP
Unlock Faster, More Accurate Drug Discovery with XFEP
Intelligent Cloud-Based Algorithms for Pharmaceutical Drug Formulation and Development
05
News & Events
XtalPi Invests in MIT-Led Foundry Bio, Harnessing Generative AI to Transform the Trillion-Dollar Anti-Aging Market
XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations 
XtalPi Announces Strategic Acquisition of Liverpool ChiroChem (LCC), Unlocking Unprecedented Power in Chemical Space Exploration

XtalPi Newsletter